Skip to main content
Clinical Trials/IRCT20210814052178N1
IRCT20210814052178N1
Recruiting
Phase 3

Formulation and evaluation of the effectiveness of Berberpim® syrup in patients with Non-alcoholic fatty liver disease: A randomized clinical trial study

Kermanshah University of Medical Sciences0 sites46 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Kermanshah University of Medical Sciences
Enrollment
46
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age over 18 years
  • Patients with grade I and II Non\-alcoholic fatty liver disease according to the results of ultrasound, clinical interview, increase in liver enzymes and elimination of other causes this disease affects Non\-alcoholic fatty liver

Exclusion Criteria

  • Patients with Hepatitis
  • Wilson's disease
  • People who drink alcohol
  • People with type I diabetes and type II diabetes who have been taking the drug for a year
  • Consumers of drugs that affect the level of liver enzymes such as Statins and Acetaminophen in high doses

Outcomes

Primary Outcomes

Not specified

Similar Trials